ELDN

1.7806.32%
PS

Paul Sean Little

Chief Financial Officer

Mr. Paul Sean Little serves as Chief Financial Officer at Eledon Pharmaceuticals, Inc. since March 15, 2021 and serves as Principal Accounting Officer since July 31, 2021. He had been Chief Financial Officer, Senior Vice President and Treasurer at Sientra, Inc. since August 8, 2018 until March 12, 2021. Mr. Little served as the Global Chief Operating Officer of Syneron Medical Ltd. since November 8, 2016 until September 2017. Mr. Little has experience in finance, business strategy and operations roles, spanning pharmaceutical, medical device, consumer packaged goods and public accounting industries. He joined Eledon Pharmaceuticals, Inc. in March 2021. From 2004 to 2016, he held roles of increasing responsibility at Allergan PLC. Most recently, he served as Vice President of Finance and Head of Commercial Operations of Allergan Medical Aesthetics, where he built the finance and commercial operations functions which included market leading products such as BOTOX ® Cosmetic and JUVÉDERM. He was a member of the leadership team that resulted in key strategic business acquisitions including Inamed, SkinMedica and Kythera Biopharmaceuticals. Post-acquisition, he led both finance and commercial operations integration activities. Prior to Allergan, Mr. Little spent with ConAgra Foods in leadership roles of increasing responsibility, most notably Vice President of Finance, International Foods Group, where he was responsible for international accounting and strategic and operational planning. He began his career in public accounting at KPMG. He earned a BA in Business Economics from the University of California, Santa Barbara.

Positions